Infliximab safety profile and long-term applicability in inflammatory bowel disease: clinical experiences from the eastern side of Europe

Aliment Pharmacol Ther. 2010 May;31(10):1152-3. doi: 10.1111/j.1365-2036.2010.04260.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Child
  • Europe, Eastern
  • Female
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Inflammatory Bowel Diseases / mortality
  • Infliximab
  • Male
  • Middle Aged
  • Prospective Studies
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab